ALPS Medical Breakthroughs ETF (SBIO) |
| 41.04 -0.46 (-1.11%) 10-10 15:56 |
| Open: | 41.64 |
| High: | 41.64 |
| Low: | 40.51 |
| Volume: | 111,223 |
| Market Cap: | 93(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 48.64 |
| Resistance 1: | 41.64 |
| Pivot price: | 39.02 |
| Support 1: | 37.80 |
| Support 2: | 35.43 |
| 52w High: | 42.73 |
| 52w Low: | 22.33 |
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 07 Oct 2025
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
Thu, 11 Sep 2025
3 Stocks Driving Biotech ETF SBIO’s Appeal - ETF Trends
Fri, 29 Aug 2025
This Underrated Tech ETF Is Spiking Amid Rate Cut Hype - ETF Trends
Fri, 15 Aug 2025
Is Biotech the Right Tech ETF Move Right Now? SBIO Argues Yes - ETF Trends
Thu, 10 Jul 2025
Small-Cap Biotech Stocks Ready to Shine - ETF Trends
Mon, 30 Jun 2025
5 Small-cap Biotech ETFs to Watch - Nasdaq
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
